Selective and enhanced recovery of group A and B streptococci from throat cultures with sheep blood agar containing sulfamethoxazole and trimethoprim.
Sheep blood agar containing 23.75 microgram of sulfamethoxazole and 1.25 microgram of trimethoprim (SXT-BA) per ml was compared with conventional sheep blood agar (SBA) for isolating group A and B streptococci from throat cultures. This selective medium allowed much better recovery of group A and B streptococci and suppressed the growth of the normal flora, including "viridans" streptococci. In an initial study of 700 throat cultures, SXT-BA recovered 42% more group A and 49% more group B streptococci than did SBA. When SXT-BA was introduced into the routine microbiology laboratory and used by a number of medical technologists. SXT-BA recovered 28% more group A and 37% more group B streptococci than did SBA. In addition, the selective medium inhibited 83% of the non-group A and B streptococci that were recovered by SBA.
D000362:Agar; D000818:Animals; D001769:Blood; D005069:Evaluation Studies as Topic; D006801:Humans; D010614:Pharynx / Q000382:microbiology*; D012756:Sheep; D013045:Species Specificity; D013292:Streptococcus agalactiae / Q000254:growth & development / Q000302:isolation & purification*; D013297:Streptococcus pyogenes / Q000254:growth & development / Q000302:isolation & purification*; D013420:Sulfamethoxazole; D014295:Trimethoprim
D000362:Agar; D014295:Trimethoprim; D013420:Sulfamethoxazole